Contemporary Treatment of Borderline Ovarian Tumors

References

• Parker S L, Tong T, Bolden S, et al. Cancer statistics, 1997. CA Cancer J Clin 1997; 475–27
   Google Scholar
• Taylor H C. Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet 1929; 48: 204–230
   Google Scholar
• International Federation of Gynecology and Obstetrics: Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scand 1971; 50: 1–7
   PubMed Web of Science ®Google Scholar
• Serov S F, Scully R E, Solvin L H. International histologic classification of tumors no. 9, histologic typing of ovarian tumors. World Health Organization, Geneva 1973; 37–41
   Google Scholar
• Czernobilsky B. Common epithelial tumors of the ovary. Blaustein's Pathology of the Female Genital Tract, 3rd ed., R J Kuman. Springer-Verlag, New York 1987; 560–606
   Google Scholar
• Hopkins M P, Morley G W. The second-look operation and surgical reexploration in ovarian tumor of low malignant potential. Obstet Gynecol 1989; 74: 375–378
   PubMed Web of Science ®Google Scholar
• Yazigi R, Sandstad J, Munoz A K. Primary staging in ovarian tumors of low malignant potential. Gynecol Oncol 1988; 31: 402–408
   PubMed Web of Science ®Google Scholar
• Snider D D, Stuart G CE, Nation J G, et al. Evaluation of surgical staging in Stage I low malignant potential ovarian tumors. Gynecol Oncol 1991; 40: 129–132
   PubMed Web of Science ®Google Scholar
• Rice L W, Berkowitz R S, Mark S D, et al. Epithelial ovarian tumors of borderline malignancy. Gynecol Oncol 1990; 39: 195–198
   PubMed Web of Science ®Google Scholar
• Casey A C, Bell D A, Lage J M, et al. Epithelial ovarian tumors of borderline malignancy: long-term follow-up. Gynecol Oncol 1993; 50: 316–322
   PubMed Web of Science ®Google Scholar
• Tazelaar H D, Bostwick D G, Ballon S C, et al. Conservative treatment of borderline ovarian tumors. Obstet Gynecol 1985; 66: 417–422
   PubMed Web of Science ®Google Scholar
• Lim-Tan S K, Cajigas H E, Scully R E. Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases. Obstet Gynecol 1988; 72: 775–781
   PubMed Web of Science ®Google Scholar
• Bamhill D R, Kurman R J, Brady M F, et al. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group Study. J Clin Oncol 1995; 13: 2752–2756
   PubMed Web of Science ®Google Scholar
• Silva E G, Tomos C, Zhuang Z, et al. Tumor recurrence in Stage I ovarian serous neoplasms of low malignant potential. Int J Gynecol Pathol 1998; 17: 1–6
   PubMed Web of Science ®Google Scholar
• Hart W R, Noms H J. Borderline and malignant rnucinous tumors of the ovary: histologic criteria and clinical behavior. Cancer 1973; 31: 1031–1045
   PubMed Web of Science ®Google Scholar
• Guerrieri C, Hogberg T, Wingren S, et al. Mucinous borderline and malignant tumors of the ovary: a clinicopathologic and DNA ploidy study of 92 cases. Cancer 1994; 74: 2329–2340
   PubMed Web of Science ®Google Scholar
• Bostwick D G, Tazelaar H D, Ballon S C, et al. Ovarian epithelial tumors of borderline malignancy: a clinical and pathologic study of 109 cases. Cancer 1986; 58: 2052–2065
   PubMed Web of Science ®Google Scholar
• Leake J F, Cume J L, Rosenshein N B, et al. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol 1992; 47: 150–158
   PubMed Web of Science ®Google Scholar
• Kennedy A W, Hart W R. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). Cancer 1996; 78: 178–286
   PubMedGoogle Scholar
• Kaern J, Tropi C G, Abeler V M. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982 a review of clinicopathologic features and treatment modalities. Cancer 1993; 71: 1810–1820
   PubMed Web of Science ®Google Scholar
• Chambers J T, Merino M J, Kohorn E I, et al. Borderline ovarian tumors. Am J Obstet Gynecol 1988; 159: 1088–1094
   PubMed Web of Science ®Google Scholar
• Massad L S, Hunter V J, Szpak C A, et al. Epithelial ovarian tumors of low malignant potential. Obstet Gynecol 1991; 78: 1027–1032
   PubMed Web of Science ®Google Scholar
• Barnhill D, Heller P, Brzozowski P H, et al. Epithelial ovarian carcinoma of low malignant potential. Obstet Gynecol 1985; 65: 53–59
   PubMed Web of Science ®Google Scholar
• Nation J G, Krepart G V. Ovarian carcinoma of low malignant potential: staging and treatment. Am l Obstet Gynecol 1986; 154: 290–293
   PubMed Web of Science ®Google Scholar
• Hopkins M P, Kumar N B, Morley G W. An assessment of pathologic features and treatment modalities in ovarian tumors of low malignant potential. Obstet Gynecol 1987; 70: 923–929
   PubMed Web of Science ®Google Scholar
• Fort M G, Pierce V K, Saigo P E, et al. Evidence for the efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1989; 32: 269–272
   PubMed Web of Science ®Google Scholar
• Kliman L, Rome R M, Fortune D W. Low malignant potential tumors of the ovary: a study of 76 cases. Ohstet Gynecol 1986; 68: 338–344
   PubMed Web of Science ®Google Scholar
• Manchul L A, Simm J, Lein W, et al. Borderline epithelial ovarian tumors: a review of 81 cases with an assessment of the impact of treatment. Int J Radiat Oncol Biol Phys 1992; 22: 867–874
   PubMed Web of Science ®Google Scholar
• Russell P. Borderline epithelial tumours of the ovary: a conceptual dilemma. Clin Obstet Gynecol 1984; 11: 259–276
   Google Scholar
• Michael H, Roth L M. Invasive and noninvasive implants in ovarian serous tumors of low malignant potential. Cancer 1986; 57: 1240–1247
   PubMed Web of Science ®Google Scholar
• McCaughey W E, Kirk M E, Lester W, et al. Peritoneal epithelial lesions associated with proliferative serous tumours of ovary. Histopathology 1984; 8: 195–208
   PubMed Web of Science ®Google Scholar
• Bell D A, Weinstock M A, Scully R E. Peritoneal implants of ovarian serous borderline tumors. Cancer 1988; 62: 2212–2222
   PubMed Web of Science ®Google Scholar
• DeNictolis M, Montironi R, Tommasoni S, et al. Serous borderline tumors of the ovary: a clinicopathologic, immunohistochemical, and quantitative study of 44 cases. Cancer 1992; 70: 152–160
   PubMed Web of Science ®Google Scholar
• Seidman J D, Kurman R J. Subclassification of serous borderline tumors of the ovary into benign and malignant types. Am J Surg Pathol 1996; 20: 1331–1345
   PubMed Web of Science ®Google Scholar
• Gershenson D M, Silva E G. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer 1990; 65: 578–585
   PubMed Web of Science ®Google Scholar
• Gershenson D M, Silva E G, Levy L, et al. Serous borderline tumors of the ovary with invasive peritoneal implants. Cancer 1998; 82: 1096–1103
   PubMed Web of Science ®Google Scholar
• Gershenson D M, Silva E G, Tortolero-Luna G, et al. Serous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer, (in press)
   Web of Science ®Google Scholar
• Gotlieb W H, Flikker S, Davidson B, et al. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome. Cancer 1998; 82: 141–146
   PubMed Web of Science ®Google Scholar